Behavioral Exercise Training to Reduce Cardiovascular Disease Risk
Trial statusRecruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexMale
Age40-85
SponsorVirginia Commonwealth University
About this trial
To test the preliminary effectiveness of a home-based exercise training (ET) intervention to improve exercise capacity (VO2 peak \& 6-minute walk distance \[6MWD\]) among prostate cancer (PC) patients compared to controls receiving healthy living education (HLE) at 12 weeks.
Eligibility criteria
Qualifiers
Be diagnosed with stage II/III/IV prostate cancer
Be currently undergoing treatment with ADT (intermittent or prolonged)
Have completed local curative-intent treatment, including prostatectomy or definitive radiation;
Be >40 years of age up to 85;
Disqualifiers
Be unable to undergo MRI (i.e., ferromagnetic materials in body, inability to lie flat, claustrophobia);
Have contraindications to exercise testing;
Have pre-existing overt cardiovascular disease/heart failure;
Active illness/infection;
Trial design
Treatments tested in this trial
- Exercise Training Intervention
- Healthy Living Education
Treatment groups
60 Participants
are divided into 2 treatment groupsLocations
2Richmond Veterans Affairs Medical Center23249, RichmondVirginia, United States
Virginia Commonwealth University Massey Cancer Center23298, RichmondVirginia, United States
Sponsors and collaborators
Virginia Commonwealth University
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Source ClinicalTrials.gov